Updated Recommendations for use of Haemophilus influenzae Type b (Hib) Vaccine: Reinstatement of the Booster Dose at Ages 12-15 Months

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Updated Recommendations for use of Haemophilus influenzae Type b (Hib) Vaccine: Reinstatement of the Booster Dose at Ages 12-15 Months

Published Date:

June 26, 2009

Status:

retired

Source:

MMWR. Morbidity and mortality weekly report. 2009; 58(24):673-4.

Language:

English

[HTML]

This is an HTML document so it cannot be previewed.

To open, click the "View" button.

Details:

Alternative Title:

MMWR. Morbidity and mortality weekly report

Corporate Authors:

United States. Advisory Committee on Immunization Practices. ; American Academy of Family Physicians. ; American Academy of Pediatrics. ;

Description:

On December 13, 2007, certain lots of Haemophilus influenzae type b (Hib) vaccine marketed as PedvaxHIB (monovalent Hib vaccine) and Comvax (Hib-HepB vaccine), and manufactured by Merck & Co., Inc., were recalled voluntarily, and the company temporarily suspended production of these vaccines. To conserve the limited supply of Hib-containing vaccines, CDC, in consultation with the Advisory Committee on Immunization Practices (ACIP), the American Academy of Family Physicians (AAFP), and the American Academy of Pediatrics (AAP), on December 18, 2007, recommended that vaccination providers temporarily defer the routine Hib vaccine booster dose administered to most healthy children at age 12-15 months

Subject:

[+]

Pubmed ID:

19553904

Document Type:

Journal Issue

Collection(s):

Advisory Committee on Immunization Practices (ACIP)
Guidelines and Recommendations

Main Document Checksum:

[+]

Supporting Files:

No Additional Files

No Related Documents.

You May Also Like:

MMWR. Morbidity and mortality weekly report, Vol. 58, no. 24, June 26, 2009

Corporate Authors:

Centers for Disease Control and Prevention (U.S.)

Published Date:

June 26, 2009

Series:

MMWR. Morbidity and mortality weekly report ; v. 48, no. 24

File Type:

[PDF - 1.28 MB]
DBD bulletin ; issue 03, summer 2009

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Bacterial Diseases.

Published Date:

summer 2009

Series:

DBD bulletin ; issue 3

File Type:

[PDF - 240.95 KB]
Haemophilus influenzae Type b Disease and Vaccine Booster Dose Deferral, United States, 1998–2009

Personal Author:

Briere, Elizabeth C.; Jackson, Michael; Shah, Shetul G.; Cohn, Amanda C.; Anderson, Raydel D.; MacNeil, Jessica R.; Coronado, Fatima M.; Mayer, Leonard W.; Clark, Thomas A.; Messonnier, Nancy E.;

Published Date:

Aug 06 2012

Source:

Pediatrics. 130(3):414-420.

Description:

BACKGROUNDSince the introduction of effective vaccines, the incidence of invasive Haemophilus influenzae type b (Hib) disease among children <5 years of age has decreased by 99% in the United States. In response to a limited vaccine supply that began...

File Type:

[PDF - 319.97 KB]
National, State, and Local Area Vaccination Coverage Among Children Aged 19–35 Months — United States, 2012

Personal Author:

Black, Carla L.; Yankey, David; Kolasa, Maureen;

Published Date:

Sep 13 2013

Source:

MMWR Morb Mortal Wkly Rep. 2013; 62(36):733-740.

Description:

The National Immunization Survey (NIS) is a random-digit-dialed telephone survey used to monitor vaccination coverage among U.S. children aged 19-35 months. This report describes national, state, and selected local area vaccination coverage estimates...

File Type:

[PDF - 519.29 KB]
MMWR. Morbidity and mortality weekly report, Vol. 59, no. 33, August 27, 2010

Corporate Authors:

Centers for Disease Control and Prevention (U.S.)

Published Date:

August 27, 2010

Series:

MMWR. Morbidity and mortality weekly report ; v. 59, no. 33

File Type:

[PDF - 1.93 MB]